Raleigh, N.C. — Visiclear Tablets, a colon cleansing product owned by Salix Pharmaceuticals, will go on sale in Japan on June 15.
Zeria Pharmaceutical of Tokyo licensed Visiclear from Salix. Zeria obtained rights to the drug in 2001 from InKine Pharmaceuticals, which Salix acquired in 2005.
The product is sold in the U.S. under the name Visicol.
The drug is used to prepare people for colonoscopy exams.
Related Items
On The Web
Related Topics
![[search]](http://wwwcache.wral.com/presentation/v1/images/icons/16x12/search-form-icon.gif)
Site Search
Salix Product Nears Market in Japan
Copyright 2008 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
News Alerts to your Email & Cell Phone-
- Argos Therapeutics wraps up remainder of $35.2M in financing
Updated Nov. 21 3:06 p.m. - Internet Summit - Lots of highs, a few lows
Updated Nov. 21 1:19 p.m. - N.C. adds jobs but unemployment rate reaches 7%
Updated Nov. 21 10:16 p.m. - Duke cardiologist could be next head of FDA
Nov. 21, 2008 - Future shock? A more dangerous world looms, warns new report
Updated Nov. 21 8:51 a.m.
- Argos Therapeutics wraps up remainder of $35.2M in financing
-
- What do entrepreneurs do now?
Nov. 20, 2008 - Internet Summit consensus: SaaS is hot!
Nov. 20, 2008 - Atlanta chip startup VT Silicon lands $5.5M in financing
Nov. 20, 2008 - Quit building mansions and focus on execution, Lulu’s Bob Young says
Nov. 20, 2008 - Interact911 closes on $28M in new financing
Nov. 20, 2008
- What do entrepreneurs do now?
More from wrallocaltechwire.com
Market Watch
